title: Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases.
abstract: Triggering of the Fas receptor induces T cell apoptosis and is involved in shutting-off the immune response. Inherited defects impairing Fas function cause the autoimmune lymphoproliferative syndrome, and may play a role in other autoimmune diseases. The aim of this work was to analyse the Fas function in paediatric patients with thyroid autoimmunities. We found that T cells from 24/28 patients with Graves' disease (GD) and 12/35 patients with Hashimoto's thyroiditis (HT) displayed defective Fas function. In HT, the defect was more frequent in patients requiring replacement therapy (11/20) than in those not requiring (1/15); moreover, in untreated HT the highest defect was displayed by patients with the highest levels of autoantibodies. Fas was always expressed at normal levels and no Fas mutations were detected. Analysis of the healthy parents of seven Fas-resistant patients showed that several of them were Fas-resistant, which suggests a genetic component. Fusion of Fas-resistant T cells with the Fas-sensitive HUT78 T cell line generated Fas-resistant hybrid cells, which suggests the presence of molecules exerting a dominant negative effect on Fas function. Analysis of Fas-induced activation of caspase-8 and -9 showed decreased activity of both caspases in HT, whereas activity of caspase-9 was increased and that of caspase-8 was decreased in GD. These data suggest that heterogeneous inherited defects impairing Fas function favour the development of thyroid autoimmunities.
authors.affiliation: Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Sciences, 'A.Avogadro' University of Eastern Piedmont, Novara, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Bona
authors.forename: S
authors.initials: S
authors.lastname: Defranco
authors.forename: A
authors.initials: A
authors.lastname: Chiocchetti
authors.forename: M
authors.initials: M
authors.lastname: Indelicato
authors.forename: A
authors.initials: A
authors.lastname: Biava
authors.forename: D
authors.initials: D
authors.lastname: Difranco
authors.forename: I
authors.initials: I
authors.lastname: Dianzani
authors.forename: U
authors.initials: U
authors.lastname: Ramenghi
authors.forename: A
authors.initials: A
authors.lastname: Corrias
authors.forename: G
authors.initials: G
authors.lastname: Weber
authors.forename: V
authors.initials: V
authors.lastname: De Sanctis
authors.forename: L
authors.initials: L
authors.lastname: Iughetti
authors.forename: G
authors.initials: G
authors.lastname: Radetti
authors.forename: U
authors.initials: U
authors.lastname: Dianzani
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D017209:Apoptosis; D016022:Case-Control Studies; D053181:Caspase 8; D053453:Caspase 9; D020169:Caspases / Q000378:metabolism; D002460:Cell Line; D002648:Child; D004789:Enzyme Activation; D005260:Female; D006111:Graves Disease / Q000235:genetics / Q000276:immunology*; D006801:Humans; D006825:Hybridomas; D008213:Lymphocyte Activation; D008297:Male; D013601:T-Lymphocytes / Q000166:cytology / Q000201:enzymology / Q000276:immunology*; D013967:Thyroiditis, Autoimmune / Q000235:genetics / Q000276:immunology*; D019014:fas Receptor / Q000276:immunology*
chemical_list: D019014:fas Receptor; C505530:CASP8 protein, human; C506433:CASP9 protein, human; D053181:Caspase 8; D053453:Caspase 9; D020169:Caspases